arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

CDT Equity Inc.

CDT

$3.42 ▲ +0.05 (+1.63%) at close

5 Visible periods

19 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Neutral Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, CDT Equity Inc. shows mixed fundamentals. Return on Invested Capital remain bright spots. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 405.0% ↗

FCF / Share None

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

5-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-39.22M

↓ -120.3% —

FCF / Share Free cash flow per share

$-11.22

↑ +2.7% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

Return on Invested CapitalReturn on Invested Capital of 405.0% is excellent on an absolute basis (target > 10%)

warning

Bearish Risks

Interest CoverageInterest Coverage of -183.78x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.40x is weak on an absolute basis (target > 1x)

Health Breakdown

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Mar 31, 2023 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
EPS Growth YoY (%)	-5637.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-2498.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-507.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-120.3% Weak ↑ Weak Improving Year-over-year change in net income	-3227.5% Weak Weak Year-over-year change in net income	89.1% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	—	2.7% Caution Caution Year-over-year change in free cash flow	-18961.7% Weak Weak Year-over-year change in free cash flow	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Mar 31, 2023 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
FCF / Net Income (x)	0.40x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	14.44x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.46x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Mar 31, 2023 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Return on Invested Capital (%)	405.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	179.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	909.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	24.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-650.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-367.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-72.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-63200.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	262.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1647%)	117.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+680%)	48.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+223%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Mar 31, 2023 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Interest Coverage (x)	-183.78x Weak Weak Operating income divided by interest expense Optimal: > 5x	-385.48x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-1.51M	$-554.00K	$-4.23M	—	$-48.55K

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Mar 31, 2023 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Basic EPS, GAAP (USD)	$-1.18K	$-20.53	$-0.79	$-0.13	—
Free Cash Flow per Share (USD)	—	$-11.22	$-11.53	$-0.06	—
Book Value per Share (USD)	—	$-4.91	$-0.62	$-0.16	—
Tangible Book Value per Share (USD)	—	$-4.91	$-0.62	$-0.16	—
Basic Weighted Avg Shares (shares)	33,300	867,096	669,739	37.45M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Mar 31, 2023 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Working Capital (USD)	$-8.44M	$-8.03M	$3.93M	$-3.67M	$-88.34K
Total Equity (USD)	$-7.17M	$-6.79M	$-457.00K	$-10.09M	$20.62K

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Mar 31, 2023 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Depreciation Expense (USD)	—	$10.00K	—	—	—
Net Income, GAAP (USD)	$-39.22M	$-17.80M	$-535.00K	$-4.89M	—
Operating Cash Flow (USD)	$-15.55M	$-9.68M	$-7.72M	$-2.27M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 5 years · 18 quarters

CDT Equity Inc.

Analytical Summary

5-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare CDT with peers